May/June 2026
May/June 2026 | Medical Retina
Drug Interactions in Immunosuppressive Therapy for Uveitis
A review of the toxic relationships to avoid when managing patients with uveitis.
Ioannis Papasavvas, MD, and Carl P. Herbort, Jr, MD, PD
May/June 2026 | Features
Landmark Trials in AMD
A summary of the clinical trials that have shaped—and continue to shape—how we treat AMD.
Saghar Bagheri, MD, PHD; Alberto Quarta, MD; Rouzbeh Abbasgholizadeh, MD; Alessandro Feo, MD; Paolo Forte, MD; David Sarraf, MD; Michael S. Ip, MD; and SriniVas R. Sadda, MD, FARVO
Popular Articles
April 2026 Insert
One to Watch: Samir N. Patel, MD
Samir N. Patel, MD
March 2026 Supplement | Digital Supplement
From Vascular Curiosity to Neurodegenerative Disease: A Consensus Statement for the Diagnosis and Management of Macular Telangiectasia Type 2
Lejla Vajzovic, MD, FASRS; Sophie Bakri, MD; W. Lloyd Clark, MD; Diana Do, MD; Dean Eliott, MD; Roger Goldberg, MD; and Dante Pieramici, MD
May/June 2026 Supplement | Editorial
The Economics Of Care
Alan Ruby, MD
January/February 2026 Supplement
Introducing ENCELTO Into Retina Practices
David Chin Yee, MD, and Jiong Yan, MD